A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To evaluate the safety and tolerability of a single dose of 600 mg AZD7442 administered IV (intravenous) to Chinese adults (including those with stable medical conditions).
Epistemonikos ID: 4345e2623c72a9d1b788594ed89221a1c63ac3f8
First added on: Jan 12, 2022